Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 7:12:3481-3489.
doi: 10.2147/OTT.S191247. eCollection 2019.

miR-125a-5p inhibits colorectal cancer cell epithelial-mesenchymal transition, invasion and migration by targeting TAZ

Affiliations

miR-125a-5p inhibits colorectal cancer cell epithelial-mesenchymal transition, invasion and migration by targeting TAZ

Lei Tang et al. Onco Targets Ther. .

Abstract

Background: miR-125a-5p regulated biological processes in various types of cancer, including colorectal cancer (CRC). TAZ, a vital transcriptional coactivators of the Hippo pathway, was found to be overexpressed in various cancers. Objectives: This study aims to study the effect of miR-125a-5p on the progression of CRC by regulating TAZ expression. Methods: In this study, miR-125a-5p and TAZ expression in CRC tissue and cell lines were detected by real-time polymerase chain reaction (RT-PCR). Luciferase reporter assay was applied to detect whether TAZ was a target of miR-125a-5p. Cell migration and invasion were detected in vitro by wound-healing assay and cell invasion assay. Western blot was used to detect the expression of epithelial-mesenchymal transition (EMT)-related proteins. Findings: The results revealed downregulation of miR-125a-5p, as well as upregulation of TAZ in CRC tissue and cell lines. TAZ was identified as a direct target of miR-125a-5p, and its expression was negatively regulated by miR-125a-5p in CRC cell lines. The functional studies revealed that overexpression of miR-125a-5p inhibited the migration, invasion and EMT of CRC cells, while upregulation of TAZ reversed the inhibitory effect caused by miR-125a-5p. Conclusion: Our data suggest that miR-125a-5p inhibits CRC cell migration, invasion and EMT by targeting TAZ. These results suggest that miR-125a-5p serves as a potential therapeutic biomarker for CRC patients.

Keywords: TAZ; colorectal cancer; epithelial–mesenchymal transition; invasion; miR-125a-5p; migration.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
miR-125a-5p was downregulated in CRC tissues and cell lines. (A) The expression of miR-125a-5p in colorectal cancer and adjacent tissues was determined by qRT-PCR. (B) The expression of miR-125a-5pin five CRC cell lines LoVo, SW480, SW620, HCT116, HT29 and NCM460 was detected by qRT-PCR. Dates are expressed by mean ± standard deviation. (A) ***P<0.001 vs colorectal cancer adjacent tissues; (B) **P<0.01, ***P<0.001 vs NCM460. Abbreviations: CRC, colorectal cancer; NCM460, normal colonic mucosa epithelial cells; miR-125a-5p, microRNA-125a-5p.
Figure 2
Figure 2
TAZ was upregulated in CRC cells and is a direct target gene of miR-125a-5p. (A) The mRNA expression of TAZ in CRC tissues was determined by qRT-PCR. The mRNA and protein expression of TAZ in CRC cell lines LoVo, SW480, SW620, HCT116, HT29 was determined by qRT-PCR (B) and Western blot (C). (D) Luciferase activity was detected in cells co-transfected with TAZ 3ʹUTR WT/MUT and miR-125a-5p mimic/mimic control by dual-luciferase reporter assay. Protein expression levels of TAZ in LoVo (E) and SW480 (F) cells transfected with miR-125a-5p mimic or mimic control was detected by Western blot. mRNA expression levels of TAZ in LoVo (G) and SW480 (H) cells transfected with miR-125a-5p mimic or mimic control was detected by qRT-PCR. Dates are expressed by mean ± standard deviation. (A) ***P<0.001 vs colorectal cancer adjacent tissues. (B and C) *P<0.05, **P<0.01, ***P<0.001 vs NCM460. (DH) **P<0.01, ***P<0.001 vs control. Abbreviations: CRC, colorectal cancer; NCM460, normal colonic mucosa epithelial cells; miR-NC, microRNA mimic control; miR-125a-5p, microRNA-125a-5p.
Figure 3
Figure 3
miR-125a-5p inhibits migration and invasion of CRC cells via directly targeting TAZ. Protein expression levels of TAZ in LoVo (A) and SW480 (B) cells transfected with miR-125a-5p mimic or mimic control were detected by Western blot. (C) Wound-healing assays were used to examine cell migration of LoVo and SW480 cells transfected with miR-NC, miR-125a-5p mimic or co-transfected with miR-125a-5p mimic and TAZ overexpression plasmids. (D) Transwell assays were used to examine cell invasion of LoVo and SW480 cells transfected with miR-NC, miR-125a-5p mimic or co-transfected with miR-125a-5p mimic and TAZ overexpression plasmids. Dates are expressed by mean ± standard deviation. **P<0.01, vs control. ##P<0.01, ###P<0.001 vs miR-125a-5p mimic. Abbreviations: miR-NC, microRNA mimic control; PCDNA3-TAZ, TAZ overexpression plasmids.
Figure 4
Figure 4
miR-125a-5p inhibits epithelial–mesenchymal transition of CRC cells via directly targeting TAZ. Western blot was used to examine the protein expression of EMT markers E-cadherin, N-cadherin, vimentin and β-catenin in LoVo (A) and SW480 (B) cells transfected with miR-NC, miR-125a-5p mimic or co-transfected with miR-125a-5p mimic and TAZ overexpression plasmids. Dates are expressed by mean ± standard deviation. **P<0.01, ***P<0.01 vs miR-NC. ##P<0.01, ###P<0.01 vs miR-125a-5p mimic. Abbreviations: miR-NC, microRNA mimic control; PCDNA3-TAZ, TAZ overexpression plasmids.

Similar articles

Cited by

References

    1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386. doi:10.1002/ijc.29210 - DOI - PubMed
    1. Van Cutsem E, Cervantes A, Nordlinger B, Arnold D. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):i1–i9. doi:10.1093/annonc/mdu061.1 - DOI - PubMed
    1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–117. doi:10.3322/caac.21220 - DOI - PubMed
    1. Cao H, Xu E, Liu H, Wan L, Lai M. Epithelial-mesenchymal transition in colorectal cancer metastasis: a system review. Pathol Res Pract. 2015;211:557–569. doi:10.1016/j.prp.2015.05.010 - DOI - PubMed
    1. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302:1–12. doi:10.1016/j.ydbio.2006.08.028 - DOI - PubMed